Kalera Public Limited Company Announces $10M Private Placement

alera Public Limited Company ("Kalera" or the "Company") (NASDAQ:KAL), a vertical farming company headquartered in Orlando, Florida, announced today that it has entered into a securities purchase

alera Public Limited Company (“Kalera” or the “Company”) (NASDAQ:KAL), a vertical farming company headquartered in Orlando, Florida, announced today that it has entered into a securities purchase agreement with a single institutional investor to raise approximately $10.0 million through the private placement of 2,500,000 shares of common stock (or pre-funded warrants in lieu thereof), 2,500,000 Series A Warrants and 2,500,000 Series B Warrants. Each share of common stock (or pre-funded warrant in lieu thereof) is being sold together with accompanying warrants at a combined effective purchase price of $4.00. The Series A Warrants will be exercisable six months from the date of issuance at an exercise price of $4.41 per share and will expire two years from the date of issuance. The Series B Warrants will be exercisable six months from the date of issuance at an exercise price of $4.41 per share and will expire five and a half years from the date of issuance. The closing of the private placement is expected to occur on July 11, 2022, subject to the satisfaction of certain customary closing conditions set forth in the securities purchase agreement.
 

Total
0
Shares
Related Posts
Read More

AstraZeneca, Merck Report Results From OlympiA Phase 3 Trial Of LYNPARZA For Patients With Germline Breast Cancer Gene-Mutated High-Risk Early Breast Cancer Showed Statistical Significance, Clinically Meaningful Improvement In Survival

First medicine targeting BRCA mutations to show clinical benefit in adjuvant setting WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca and Merck & Co., Inc., known as MSD outside the US and Canada, today announced

AZN